Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 7;23(2):1-9.
doi: 10.1007/s40200-020-00702-1. eCollection 2024 Dec.

Thyroid Cancer research at endocrinology and metabolism research institute (EMRI): a report of scientific activities between 2005 and 2020

Hilda Samimi  1 , Nooshin Shirzad  1   2 , Sayed Mahmoud Sajjadi-Jazi  3   1 , Ramin Heshmat  4 , Mahsa M Amoli  5 , Mohammad Reza Mohajeri-Tehrani  1 , Seyed Mohammad Tavangar  6 , Bagher Larijani  1 , Vahid Haghpanah  1   7
Affiliations
Review

Thyroid Cancer research at endocrinology and metabolism research institute (EMRI): a report of scientific activities between 2005 and 2020

Hilda Samimi et al. J Diabetes Metab Disord. .

Abstract

Purpose: Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences, has achieved many advances in the understanding of epidemiology, pathology, and molecular biology of thyroid cancer (TC). This paper will focus on published literature in the field of TC research at EMRI since its inception.

Methods: A comprehensive literature search of "Scopus", "Web of Science (ISI)", "PubMed", and "SID" databases was done to identify TC-based studies in EMRI since 2005, using the predefined keywords.

Results: All the records were reviewed. Eventually, 46 articles that met the inclusion and exclusion criteria were considered. Timeline, characteristics, and summarized findings of the included most studies have been briefly described.

Conclusion: The main focus of the TC research at EMRI is to investigate genetic and epigenetic changes as well as the cellular and molecular aspects seen more frequently in TC patients, and find out how exactly these alterations lead to more aggressive TC behavior and resistance to the conventional treatment approaches in those patients.

Keywords: Anaplastic thyroid carcinoma; Endocrinology and metabolism research institute; Follicular thyroid carcinoma; Medullary thyroid carcinoma; Papillary thyroid carcinoma.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no conflict of interest.

References

    1. Jung CK, Little MP, Lubin JH, Brenner AV, Wells SA, Sigurdson AJ, et al. The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab. 2014;99(2):E276–E85. - PMC - PubMed
    1. Fugazzola L, Elisei R, Fuhrer D, Jarzab B, Leboulleux S, Newbold K, et al. 2019 European thyroid association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid Cancer. Eur Thyroid J. 2019;8(5):227–45. - PMC - PubMed
    1. Aashiq M, Silverman DA, Na’ara S, Takahashi H, Amit M. Radioiodine-refractory thyroid Cancer: molecular basis of Redifferentiation therapies, management, and novel therapies. Cancers. 2019;11(9):1382. - PMC - PubMed
    1. Schneider DF, Chen H. New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin. 2013;63(6):373–94. - PMC - PubMed
    1. Larijani B, Mohagheghi MA, Bastanhagh MH, Mosavi-Jarrahi AR, Haghpanah V, Tavangar SM, et al. Primary thyroid malignancies in Tehran, Iran. Med Princ Pract. 2005;14(6):396–400. - PubMed

LinkOut - more resources